Prevalence of gingival overgrowth in renal transplant recipients on sirolimus immunosuppressive therapy is not clearly established.
OBJECTIVE
The authors attempted to study the gingival status of renal transplant patients receiving sirolimus immunosuppressive therapy by measuring the presence and severity of gingival overgrowth (GO) and by investigating the association between GO and sociodemographic, medical, and pharmacologic variables.


BACKGROUND
Grants from the Coordination of Improvement of Upper Level Personnel (CAPES), Brasilia, DF, Brazil, and the Foundation for Support of Research in Minas Gerais (FAPEMIG/#13016).


METHODS
Cross-sectional


METHODS
Level 3: Other evidence.


METHODS
Not applicable.
Fisher
Monica A
MA
Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, 1010 N. Kansas Street, Wichita, KS 67214, USA. mfisher2@kumc.edu <mfisher2@kumc.edu>
McCarthy
Ellen T
ET
Manz
Michael C
MC